Becton, Dickinson and Company is undervalued, trading at 12–13x P/E despite forecasted 7%–8% annual

The contract was awarded following a review by hospital experts serving on Vizient's client-led

Recognition from Vizient validates CentroVena One™ as a breakthrough innovation designed to simplify

Get rich slowly. How? Hold these stocks and reinvest the dividends they pay.

Despite facing some headwinds, these three companies still have strong long-term prospects. All thre

Representative Thomas H. Kean Jr, a Republican from New Jersey who sits on the House Energy and Comm

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Bioscienc

Becton, Dickinson's MedTech focus, innovation push and strategic partnerships support growth optimis

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies

On CNBC's “Mad Money Lightning Round,” Jim Cramer said about JFrog Ltd (NASDAQ:FROG) that the multip

One of these stocks sports a dividend yield topping 5%.

BDX launches the Elyra Thulium Fiber Laser system to streamline kidney stone care and boost workflow

New laser system is designed to help urology teams enhance efficiency, versatility, and procedural w

FRANKLIN LAKES, N.J., May 18, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a

Tom Polen, CEO of medical technology company BD, says that in the next decade AI and robotics will t

Becton, Dickinson and Company (BDX) Presents at Bank of America Global Healthcare Conference 2026 Tr

On May 11, 2026, Becton Dickinson and Co (BDX) shares fell 4.2% today, closing at $143.15. This decl

Becton, Dickinson and Company NYSE: BDX reported fiscal second-quarter revenue and adjusted earnings

Investors need to pay close attention to BDX stock based on the movements in the options market late

BDX beats second-quarter fiscal 2026 earnings and revenue estimates, driven by broad segment strengt

Becton, Dickinson and Company (BDX) Q2 2026 Earnings Call Transcript

Becton Dickinson (BDX) reported Q1 2026 earnings above consensus and provided guidance for the year.

U.S. stocks are little changed on Tuesday, but the Dow Jones Industrial Average is stealing the spot

The CNN Money Fear and Greed index improved, with the market moving to Neutral zone. Dow and Nasdaq

BDX Q1 2026 adjusted earnings of $2.91/share beats consensus of $2.81. Sales of $5.25B slightly abov

BD (Becton, Dickinson and Company) (NYSE:BDX) today announced the successful completion of the previ

US stock futures rise, Becton Dickinson, Kyndryl, Halliburton, Aecom, and ON Semiconductor expected

Market sentiment increased as stocks settled higher on Friday, with Dow Jones reaching 50,000 points

Waters Corporation (NYSE:WAT) (the "Company" or "Waters") today announced that, at t

The FDA clears Becton Dickinson's EnCor EnCompass breast biopsy system, with a U.S. launch plann

William Blair starts coverage on Waters with an Outperform rating, saying the BD merger could drive

https://ec.europa.eu/commission/presscorner/detail/en/mex_25_2796

Becton Dickinson posts Q4 earnings beat, raises FY26 EPS outlook, with strong growth in Medical and

The U.S. Commerce Department, under the Trump administration, has launched a national security revie

A fund manager who beats 99% of his peers calls Tesla stock overvalued. Here's a look at some of

U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from Pres

Elevance Health and Waters led the weekly large-cap losers, hit by weak earnings, lowered guidance,